NaviFUS treatment for drug-resistant temporal lobe seizures
Part of Brain & nervous system clinical trials.
This trial tests the NaviFUS system to treat seizures that keep happening despite seizure medicines, specifically in people with temporal lobe epilepsy. If you qualify, you would be carefully checked before and during the study, including seizure tracking and brain scans, to see whether treatment helps reduce seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have drug-resistant temporal lobe epilepsy (seizures starting in the temporal lobe).
- In the 2-month period before enrollment, you had at least 4 observable seizures, each on a different day.
- Your seizures are focal (start in one area), with or without spreading to the whole brain.
- You’ve had at least 24 hours of video-EEG (brain recording) and full epilepsy workup confirming your seizure start zone is in the temporal lobe.
- You can keep your seizure diary and complete study visits and English neuropsychological testing (with an English-speaking study partner if needed).
- Your seizure medicines are expected to stay the same during the trial, except for rescue medicine or occasional extra doses as needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a low-intensity focused ultrasound device that aims to calm overactive brain areas causing seizures. It's for people whose seizures are not controlled by medication.
This study tests a new device called NaviFUS that uses focused sound waves to gently stimulate a small area of the brain. It is for people whose seizures start in one part of the brain and are not fully controlled by seizure medicines.
This trial tests a low-intensity focused ultrasound treatment aimed at reducing seizures caused by problems in one side of the hippocampus (a brain area involved in memory and seizures). It’s for people whose seizures have not responded to several seizure medicines and who have been offered a specific type of surgery.
This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.
This pilot study tests whether low-intensity focused ultrasound can reduce seizures in adults whose temporal lobe epilepsy hasn’t improved with at least two anti-seizure medicines. You may be asked to track seizure timing and undergo brain imaging before and during the study.
This trial tests a new cell therapy (NRTX-1001) for people with epilepsy that starts in both sides of the brain's temporal lobes and doesn't get better with medication. It aims to reduce or stop seizures.
Hear when a new Epilepsy, Temporal Lobe trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.